SPRY2 and central nervous system cancer: In primary neurons and in C6 glioma cells, down‐regulation of Spry2 leads to the activation of Ras and ERK, whereas phosphorylation of Akt and p38 MAPK remains unchanged (Hausott et al., 2009).